Post by Logan on Jun 24, 2016 21:20:11 GMT -6
New pain drug being developed at University of Maryland could offer relief without addiction
Researchers at the University of Maryland, Baltimore have developed a new drug that promises a possible breakthrough by offering strong pain relief while lowering the risk of addiction.
The drug, a synthetic opioid called UMB425 for now, is in the early stages of development — years away from human testing — and some experts cautioned that a number of complications could prevent it from ever coming to market. But there are high hopes for the drug as the nation looks for solutions to the opioid addiction epidemic.
"It's one of the biggest health care crises we have in the United States right now," said Andrew Coop, a professor at the University of Maryland School of Pharmacy who is developing the drug. "There are people who suffer daily from the side effects of the opioid."
While opioids are generally effective for pain relief, they can lead to addiction as users become more tolerant of them and require larger doses.
Read more: www.baltimoresun.com/health/bs-hs-new-opioid-20160624-story.html
Researchers at the University of Maryland, Baltimore have developed a new drug that promises a possible breakthrough by offering strong pain relief while lowering the risk of addiction.
The drug, a synthetic opioid called UMB425 for now, is in the early stages of development — years away from human testing — and some experts cautioned that a number of complications could prevent it from ever coming to market. But there are high hopes for the drug as the nation looks for solutions to the opioid addiction epidemic.
"It's one of the biggest health care crises we have in the United States right now," said Andrew Coop, a professor at the University of Maryland School of Pharmacy who is developing the drug. "There are people who suffer daily from the side effects of the opioid."
While opioids are generally effective for pain relief, they can lead to addiction as users become more tolerant of them and require larger doses.
Read more: www.baltimoresun.com/health/bs-hs-new-opioid-20160624-story.html